Tech Company Financing Transactions
Mercury Bio Funding Round
Mercury Bio, based in Santa Fe, secured $2 million from private investors.
Transaction Overview
Company Name
Announced On
8/30/2023
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its business reach.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3900 Paseo Del Sol
Santa Fe, NM 87507
USA
Santa Fe, NM 87507
USA
Phone
Website
Email Address
Overview
We want to shift the paradigm in drug delivery systems. Mercury Bio has invented a drug delivery platform designed to unleash the potential of RNA and small-molecule drugs using reliable, cell-specific delivery--targeting only the cells that need therapy and working with the body to bypass immune reactions. Not only will our technology boost patient outcomes, it will help drug developers quicken products to market by reducing many of the obstacles, delays, and risks encountered by traditional drug delivery systems, spreading the viable reach of new medications in the process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bruce McCormick
Chief Operating Officer
Paul Laur
Browse more venture capital transactions:
Prev: 8/30/2023: Confirm venture capital transaction
Next: 8/30/2023: Context.ai venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs